Person

Susan Mahony

Formerly SVP & Pres., Lilly Oncology, Lilly (Eli)

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$6.4M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • LLY
    Lilly (Eli)
    SVP & Pres., Lilly Oncology
    2016 or earlier – last filing Feb 2019

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Apr 16, 2018LLYSale17,379$80.08$1.4M
Apr 13, 2018LLYSale5,165$80.14$414K
Dec 4, 2017LLYSale36,585$86.18$3.2M
Dec 16, 2016LLYSale19,093$72.65$1.4M
Dec 16, 2016LLYSale1,149$72.68$84K

SEC reporting-owner ID (CIK) 1463321 · all filings on EDGAR

Susan Mahony | USBoard